<DOC>
	<DOCNO>NCT01474265</DOCNO>
	<brief_summary>This study follow primary aim : - main objective study investigate effect smoke cessation quit attempt sympathovagal balance . These effect observe smoker quit smoke pharmacological support without . Secondary aim study also : - definition MSNA smokers non-smokers - investigation parameter concern autonomic nervous system , like baroreflex-sensitivity , heart rate-variability quit attempt . - definition withdrawal symptom crave , quit attempt . - investigation effect smoke cue crave sympathovagal balance - investigation relapse rate smoke cessation correlation parameter mention .</brief_summary>
	<brief_title>Sympathovagal Balance Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Men Women age 25 60 year . Group AD : Smokers willing quit smoking FTNAresult &gt; 5 . Group E : Neversmokers . Signed consent information . formerly know hypersensitivity one use pharmacological intervention structurally similar drug one ingredient . participation another study study within 4 week prior study . Addiction circumstance prevent patient estimate study consequence . Pregnancy breastfeed woman childbearing potential , except woman fulfill follow criterion : post menopause postoperative ( 6 week bothsides ovariectomy without hysterectomy ) regular correct use prevention method ( errorrate &lt; 1 % year ) , e.g . implant , depot injection , oral contraceptive , IUP ) sexual abstinence sign predict possible noncompliance patient exclusion nicorette tx : psoriasis , dermatitis , urticaria exclusion varenicline creatinineclearance &lt; 30ml/min epilepsy psychiatric disease ( schizophrenia , bipolar disorder , depression ) . Exclusion method Diseases increase sympathetic level ( Heart insufficiency , high blood pressure ( arteria /pulmonary ) , obstructive sleeping apnoea , COPD ) cardiac rhythm disturbance myocardial infarction within last 8 week polyneuropathy disease come along damage peripheral nerve severe lifethreatening disease ( e.g . cancer lifeexpectancy &lt; 5 year , terminal kidneyinsufficiency ) treatment antihypertensive drug sympathomimetic substance ( e.g.theophyllin ) smoke cessation medication ( NRT , Varenicline ) Other reason , make patient suitable study ( estimation primary investigator )</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>smoke cessation</keyword>
	<keyword>varenicline</keyword>
	<keyword>sympathovagal balance</keyword>
	<keyword>quit attempt</keyword>
	<keyword>MSNA</keyword>
</DOC>